The Cancer Genome Atlas (TCGA) Research Network is providing data and genome analysis to the cancer research community which is supporting new discoveries and accelerating the pace of cancer research. Below is a list of selected articles that describe the broad impact of TCGA on cancer research.
- September 23, 2012
Study Divides Breast Cancer Into Four Distinct Types
The New York Times reports on the The Cancer Genome Atlas Research Network's comprehensive genomic characterization of breast cancer, and their study of the four major genomic subtypes of the disease.
- September 09, 2012
Cancer Study Points to Tighter Pairing of Drugs and Patients
The New York Times reports on the findings of The Cancer Genome Atlas Research Network's comprehensive genomic characterization of lung squamous cell carcinoma and possible potential treatment from drugs in the FDA pipeline.
- July 18, 2012
Genetic Aberrations Seen as Path to Stop Colon Cancer
The New York Times reports on the findings and implications of The Cancer Genome Atlas Research Network's comprehensive genomic characterization of colorectal cancer.
- March 02, 2012
Combing the Cancer Genome
The Scientist gives a guided tour through the main online resources for analyzing data from The Cancer Genome Atlas. The article discusses tools available within the TCGA Data Portal, and outside it.
- December 23, 2011
TCGA Considered a "Notable Advance"
The Cancer Genome Atlas is considered a "Notable Advance" according to a report compiled by 18 prominent oncologists, covering the period from October 2010 to September 2011. "Notable Advances" are research that has had a significant impact on the way a cancer is understood or has had a direct impact on patient care.
- August 16, 2011
TCGA Ranks in Top Five of Most Highly Ranked Articles
In this snapshot of the most highly ranked articles in molecular biology, The Cancer Genome Atlas Research Network's article “Integrated genomic analyses of ovarian carcinoma”, published in Nature, is number five.
- July 30, 2011
Cancer-Gene Analysis Customizes Treatment
Dr. Douglas Levine, a physician and researcher at Memorial Sloan-Kettering Cancer Center, discusses the impact of understanding cancer genetics as it relates to a patient's care.
- November 30, 2010
Researchers Discover Key Mutation in Acute Myeloid Leukemia
Tim Ley, M.D., Washington University researcher, discusses the importance of a key mutation found in acute myeloid leukemia. This mutation may be an important tool to classify patients for treatment.
- November 12, 2010
Mutations in Single Gene Predict Poor Outcomes in Adult Leukemia
Washington University School of Medicine researchers discover a gene found to be commonly altered in many patients who died quickly of the disease.
- August 11, 2010
Francis Collins: One Year at the Helm
Francis Collins, Ph.D., marks his one-year anniversary as the National Institutes of Health (NIH) director. This Nature article addresses his accomplishments to date, including his investment in TCGA, and the challenges he faces ahead.